Harbor BioSciences Reports New Phase I/IIa Data at ASCO Symposium and Announces Plans

		Cancer Friends Network > Types of Cancer > Bone Cancer
Harbor BioSciences Reports New Phase I/IIa Data at ASCO Symposium and Announces Plans

LinkBack

Thread Tools

Display Modes

#1 (permalink)

03-08-2010, 03:22 PM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 85,377

Harbor BioSciences Reports New Phase I/IIa Data at ASCO Symposium and Announces Plans

SAN DIEGO -- Harbor BioSciences Inc. said today it had reported encouraging data from its ongoing Phase I/IIa clinical trial with Apoptone for castration resistant prostate cancer -- also referred to as hormone resistant prostate cancer -- at the ASCO Genitourinary Cancers Symposium in San Francisco on March 6, 2010.

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 02:04 PM.

CancerFriends.net